Published in:

01-06-1998

Phase I/II evaluation of Pentostatin (2′-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemia

Authors: S.A. Johnson, D. Catovsky, J.A. Child, A.C. Newland, D.W. Milligan, R. Janmohamed

Published in: Investigational New Drugs | Issue 2/1998